Pharmacological Treatment of Bone Loss

E-ISSN： 1873-4286|23|41|6298-6301

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.41, 2018-02, pp. : 6298-6301

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: New Strategies for the Prevention and Treatment of Bone Loss

Current Pharmaceutical Design, Vol. 23, Iss. 41, 2018-02 ,pp. : 6239-6240

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging and future therapies for the treatment of bone loss associated with chronic inflammation

By Haynes D.

Inflammopharmacology, Vol. 14, Iss. 5-6, 2006-12 ,pp. : 193-197

Springer Publishing Company

Access to resources Recommend Favorite

Background to and Management of Treatment-Related Bone Loss in Prostate Cancer

By Berruti A.

Drugs & Aging, Vol. 19, Iss. 12, 2002-01 ,pp. : 899-910

Adis International

Access to resources Recommend Favorite

Optimal Management of Cancer Treatment-Induced Bone Loss: Considerations for Elderly Patients

By Tipples Karen Robinson Anne

Drugs & Aging, Vol. 28, Iss. 11, 2011-11 ,pp. : 867-883

Adis International

Access to resources Recommend Favorite

Emerging drugs for the management of cancer treatment induced bone loss

By Bertoldo Francesco Pancheri Serena Zenari Sonia Boldini Stefania

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 323-342

Informa Healthcare

Access to resources Recommend Favorite